Profile data is unavailable for this security.
About the company
Cleo Diagnostics Limited is an ovarian cancer diagnostics company. Its principal activities involve the development and patent of a blood test for the detection of ovarian cancer. It focuses on bringing to market a blood test for the early diagnosis of ovarian cancer based on the novel CXCL10 biomarker, which is produced early and at high levels by ovarian cancers but is largely absent in non-malignant disease. It is advancing the availability of its blood test, under a modular execution strategy, which is designed to address all ovarian cancer detection markets with specific tests, including surgical triage, recurrence, high risk, and early-stage screening. It has developed a three-phased product development strategy that delivers three related tests for ovarian cancer detection: Triage Test, Recurrence Test, and Screening Test. Triage Test is a pre-surgical test to determine the likelihood that a pre-surgical ovarian mass in a patient not yet referred to an oncologist, is malignant.
- Revenue in AUD (TTM)302.22k
- Net income in AUD-3.92m
- Incorporated2021
- Employees--
- LocationCleo Diagnostics Ltd480 Collins Street, Level 2MELBOURNE 3000AustraliaAUS
- Phone+61 39614-0600
- Websitehttps://cleodx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Careteq Ltd | 7.28m | -3.04m | 3.06m | -- | -- | 0.844 | -- | 0.4207 | -0.0192 | -0.0192 | 0.0429 | 0.0154 | 0.9536 | 3.67 | 4.88 | -- | -34.69 | -- | -66.15 | -- | 90.34 | -- | -36.38 | -- | 1.32 | -30.95 | 0.151 | -- | 24.72 | -- | 17.52 | -- | -- | -- |
| Freedom Care Group Holdings Ltd | 32.67m | 1.44m | 3.82m | 34.00 | 12.06 | 3.64 | 1.97 | 0.117 | 0.0133 | 0.0133 | 0.3016 | 0.044 | 5.53 | -- | 45.58 | -- | 20.19 | -4.77 | 30.12 | -5.55 | 97.59 | -- | 3.65 | -102.13 | -- | -- | 0.1012 | -- | -- | 111.86 | -- | -- | -47.34 | -- |
| Cleo Diagnostics Ltd | 302.22k | -3.92m | 12.60m | -- | -- | 2.07 | -- | 41.68 | -0.0305 | -0.0305 | 0.0024 | 0.082 | 0.0502 | -- | 3.76 | -- | -65.13 | -- | -76.78 | -- | -- | -- | -1,296.85 | -- | -- | -28.11 | 0.00 | -- | -- | -- | -3,836.95 | -- | -- | -- |
| Genetic Technologies Ltd | 8.49m | -12.71m | 14.54m | 60.00 | -- | 2.64 | -- | 1.71 | -0.1126 | -0.1126 | 0.0752 | 0.0417 | 0.7028 | 9.84 | 4.20 | 141,514.20 | -105.21 | -52.85 | -154.00 | -61.70 | 53.55 | 49.50 | -149.69 | -247.36 | 1.55 | -- | 0.0736 | -- | 27.83 | 114.96 | -64.79 | -- | 49.00 | -- |
| Artrya Ltd | 0.00 | -11.56m | 23.61m | -- | -- | 0.9932 | -- | -- | -0.1472 | -0.1472 | 0.00 | 0.3021 | 0.00 | -- | -- | -- | -36.17 | -- | -38.11 | -- | -- | -- | -- | -- | -- | -- | 0.0435 | -- | -- | -- | 35.09 | -- | -- | -- |
| Emyria Ltd | 1.95m | -11.95m | 24.54m | -- | -- | 23.15 | -- | 12.58 | -0.0363 | -0.0363 | 0.0062 | 0.0026 | 0.275 | -- | 49.60 | -- | -168.58 | -77.78 | -321.66 | -93.49 | -12.45 | -45.04 | -612.98 | -388.17 | -- | -30.01 | 0.7573 | -- | -12.62 | -- | 29.98 | -- | -- | -- |
| Cryosite Ltd | 12.61m | 1.58m | 53.69m | 34.00 | 34.10 | 18.54 | 23.16 | 4.26 | 0.0323 | 0.0323 | 0.2582 | 0.0593 | 0.5912 | 74.83 | 7.30 | -- | 7.39 | 4.12 | 8.99 | 4.88 | 60.85 | 53.88 | 12.50 | 8.56 | 2.29 | -- | 0.4487 | -- | 1.51 | 15.04 | 3.30 | -- | 10.72 | -- |
